7.10
0.00
(0.00%)
At close: January 30 at 3:00:00 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
2,467,773.00
2,467,773.00
-1,240,413.00
-1,001,238.00
-617,775.00
Investing Cash Flow
-3,997,250.00
-3,997,250.00
-889,747.00
-579,585.00
-555,699.00
Financing Cash Flow
960,891.00
960,891.00
1,485,850.00
1,586,555.00
2,878,323.00
End Cash Position
1,542,313.00
1,542,313.00
2,092,388.00
2,641,625.00
2,684,499.00
Capital Expenditure
-879,490.00
-879,490.00
-802,498.00
-716,111.00
-448,470.00
Issuance of Capital Stock
--
--
500,466.00
992,028.00
2,714,530.00
Issuance of Debt
1,473,782.00
1,473,782.00
1,050,487.00
736,143.00
180,042.00
Repayment of Debt
-374,847.00
-374,847.00
-45,448.00
-90,760.00
-143,122.00
Repurchase of Capital Stock
--
--
--
-51,718.00
--
Free Cash Flow
1,588,283.00
1,588,283.00
-2,042,911.00
-1,717,349.00
-1,066,245.00
12/31/2020 - 5/17/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
6855.HK Ascentage Pharma Group International
33.950
-3.00%
ZLDPF Zealand Pharma A/S
100.89
0.00%
AVBP ArriVent BioPharma, Inc.
28.54
-1.89%
NBTX Nanobiotix S.A.
3.4850
-1.83%
CASI CASI Pharmaceuticals, Inc.
2.4750
+1.85%
ONCT Oncternal Therapeutics, Inc.
0.5266
-24.12%
APLM Apollomics, Inc.
8.50
-1.28%
PSTV Plus Therapeutics, Inc.
1.2400
0.00%
ENTO Entero Therapeutics, Inc.
0.4983
-0.32%
LYEL Lyell Immunopharma, Inc.
0.5903
+1.22%